Citation Impact
Citing Papers
A novel 7-modified camptothecin analog overcomes breast cancer resistance protein-associated resistance in a mitoxantrone-selected colon carcinoma cell line.
2001
A novel charged trinuclear platinum complex effective against cisplatin-resistant tumours: hypersensitivity of p53-mutant human tumour xenografts
1999
Mechanised nanoparticles for drug delivery
2009 StandoutNobel
The changing faces of glutathione, a cellular protagonist
2003
γ-Glutamyl transpeptidase is induced by 4-hydroxynonenal via EpRE/Nrf2 signaling in rat epithelial type II cells
2005
Tipin-Replication Protein A Interaction Mediates Chk1 Phosphorylation by ATR in Response to Genotoxic Stress
2010 StandoutNobel
Regulation of transcriptome, translation, and proteome in response to environmental stress in fission yeast
2012
Prevention of Preeclampsia with Heparin and Antiplatelet Drugs in Women with Renal Disease
1995
Targeted and multifunctional arene ruthenium chemotherapeutics
2011
Synthesis, characterization, activities, cell uptake and DNA binding of trinuclear complex: [{trans-PtCl(NH3)}2μ-{trans-Pt(NH3)(2-hydroxypyridine)-(H2N(CH2)6NH2)2]Cl4
2005
The novel trinuclear platinum complex BBR3464 induces a cellular response different from cisplatin
2001
Specificity of platinum–DNA adduct repair
1999
Oxidative stress, inflammation, and cancer: How are they linked?
2010 Standout
Cisplatin: mode of cytotoxic action and molecular basis of resistance
2003 Standout
Telomerase inhibitors for the treatment of cancer: the current perspective
2001
Phase II study of BBR 3464 as treatment in patients with sensitive or refractory small cell lung cancer
2006
Mechanochemistry: opportunities for new and cleaner synthesis
2011 Standout
Synthesis and structural characterization of copper(I) complexes bearing N-methyl-1,3,5-triaza-7-phosphaadamantane (mPTA)
2009
Mismatch repair and nucleotide excision repair proteins cooperate in the recognition of DNA interstrand crosslinks
2009 StandoutNobel
The resurgence of platinum-based cancer chemotherapy
2007 Standout
Developing new metal-based therapeutics: challenges and opportunities
2007
Phase II studies of BBR3464, a novel tri-nuclear platinum complex, in patients with gastric or gastro-oesophageal adenocarcinoma
2004
The influence of phenolic hydroxy substitution on the electron transfer and anti-cancer properties of compounds based on the 2-ferrocenyl-1-phenyl-but-1-ene motif
2007
DNA-based electrochemical biosensors for monitoring of bis-indoles as potential antitumoral agents, chemistry, X-ray crystallography
2005
Improved synthesis of unique estradiol-linked platinum(II) complexes showing potent cytocidal activity and affinity for the estrogen receptor alpha and beta
2008
Combination Photoimmunotherapy and Cisplatin: Effects on Human Ovarian Cancer Ex Vivo
1999
Photodynamic therapy for cancer
2003 Standout
Regulation of glutathione synthesis
2008 Standout
Recent advances in the transition metal-catalyzed twofold oxidative C–H bond activation strategy for C–C and C–N bond formation
2011 Standout
DNA Interstrand Cross-links of the Novel Antitumor Trinuclear Platinum Complex BBR3464
2002
Targeting multidrug resistance in cancer
2006 Standout
Preclinical Perspectives on Platinum Resistance
2000
Pre-eclampsia
2005 Standout
Role of Transient Receptor Potential Vanilloid 1 Receptors in Adjuvant-Induced Chronic Arthritis: In Vivo Study Using Gene-Deficient Mice
2005
Role of Oxidative Modifications in Atherosclerosis
2004 Standout
Catalytic Functionalization of Indoles in a New Dimension
2009 Standout
Cellular processing of platinum anticancer drugs
2005 Standout
γ-Glutamyltransferase, redox regulation and cancer drug resistance
2007
On the Dependency of Cellular Protein Levels on mRNA Abundance
2016 Standout
Bioorganometallic chemistry—from teaching paradigms to medicinal applications
2008 Standout
Plant Polyphenols: Chemical Properties, Biological Activities, and Synthesis
2011 Standout
Structural consequences of a 3′ → 3′ DNA interstrand cross-link by a trinuclear platinum complex: unique formation of two such cross-links in a 10-mer duplex
2009
The F Box Protein Fbx6 Regulates Chk1 Stability and Cellular Sensitivity to Replication Stress
2009
Integrated Nanoparticle–Biomolecule Hybrid Systems: Synthesis, Properties, and Applications
2004 Standout
Platinum‐based anticancer agents: Innovative design strategies and biological perspectives
2003
Physiology of Local Renin-Angiotensin Systems
2006 Standout
Tumour-inhibiting platinum complexes—state of the art and future perspectives
2003
Polynuclear platinum anticancer drugs are more potent than cisplatin and induce cell cycle arrest in glioma1
2006
Cellular pharmacology of polynuclear platinum anti-cancer agents
1999
Comparison of cytotoxicity and cellular accumulation of polynuclear platinum complexes in L1210 murine leukemia cell lines
1999
Combinatorial discovery of new asymmetric platinum anticancer complexes is made possible with solid-phase synthetic methods
2005
Contribution of the Major Copper Influx Transporter CTR1 to the Cellular Accumulation of Cisplatin, Carboplatin, and Oxaliplatin
2006
Structure and function of “metalloantibiotics”
2003
Transient Receptor Potential Cation Channels in Disease
2007 Standout
Towards Antitumor Active trans‐Platinum Compounds
2009
Catalytic CC, CN, and CO Ullmann‐Type Coupling Reactions
2009 Standout
The status of platinum anticancer drugs in the clinic and in clinical trials
2010 Standout
Impact of metal on the DNA photocleavage activity and cytotoxicity of ferrocenyl terpyridine 3d metal complexes
2011
Copper Transporters and the Cellular Pharmacology of the Platinum-Containing Cancer Drugs
2010
New Developments and Approaches in the Platinum Arena
2000
Biological Consequences of Trinuclear Platinum Complexes: Comparison of [{trans-PtCl(NH3)2}2μ-(trans-Pt(NH3)2(H2N(CH2)6-NH2)2)]4+ (BBR 3464) with Its Noncovalent Congeners
2005
Current status of the development of trans-platinum antitumor drugs
2000
Recent advances in Sonogashira reactions
2011 Standout
Cisplatin-induced injury of the renal distal convoluted tubule is associated with hypomagnesaemia in mice
2012
A ferrocenyl pyridine-based Ru(ii ) arene complex capable of generating ·OH and 1O2 along with photoinduced ligand dissociation
2016
3d Transition Metals for C–H Activation
2018 Standout
Antibacterial Activity of Graphite, Graphite Oxide, Graphene Oxide, and Reduced Graphene Oxide: Membrane and Oxidative Stress
2011 Standout
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
Biochemical Modulation of Cisplatin Mechanisms of Action: Enhancement of Antitumor Activity and Circumvention of Drug Resistance
2003 Standout
Bond Formations between Two Nucleophiles: Transition Metal Catalyzed Oxidative Cross-Coupling Reactions
2011 Standout
Bioorganometallic Chemistry of Ferrocene
2004 Standout
Photoexpulsion of Surface-Grafted Ruthenium Complexes and Subsequent Release of Cytotoxic Cargos to Cancer Cells from Mesoporous Silica Nanoparticles
2013 StandoutNobel
Magnesium in Man: Implications for Health and Disease
2014 Standout
Magnetic-field-oriented mixed-valence-stabilized ferrocenium anion-exchange membranes for fuel cells
2022
Nanozymes: Classification, Catalytic Mechanisms, Activity Regulation, and Applications
2019 Standout
Oxidative Coupling between Two Hydrocarbons: An Update of Recent C–H Functionalizations
2015 Standout
Bis- and Trisindolylmethanes (BIMs and TIMs)
2009 Standout
The Role of Cellular Accumulation in Determining Sensitivity to Platinum-Based Chemotherapy
2007
Organometallic Anticancer Compounds
2010 Standout
Anticancer and Antimicrobial Metallopharmaceutical Agents Based on Palladium, Gold, and Silver N-Heterocyclic Carbene Complexes
2007
Synthesis of PtIV‐Biomolecule Conjugates through Click Chemistry
2015
The Sonogashira Reaction: A Booming Methodology in Synthetic Organic Chemistry
2007 Standout
Occurrence, Biogenesis, and Synthesis of Biologically Active Carbazole Alkaloids
2012 Standout
Cytotoxic effect of a polymer–copper(II) complex containing 2,2′-bipyridyl ligand on human lung cancer cells
2010
Water electrolysis: from textbook knowledge to the latest scientific strategies and industrial developments
2022 Standout
DNA Mismatch Repair: Functions and Mechanisms
2005 StandoutNobel
N-Heterocyclic Carbenes in Late Transition Metal Catalysis
2009 Standout
The development of anticancer ruthenium(ii ) complexes: from single molecule compounds to nanomaterials
2017 Standout
In Vitro Antitumor Activity of the Water Soluble Copper(I) Complexes Bearing the Tris(hydroxymethyl)phosphine Ligand
2008
Formation and Repair of Interstrand Cross-Links in DNA
2005
Catalytic Dehydrogenative Cross-Coupling: Forming Carbon−Carbon Bonds by Oxidizing Two Carbon−Hydrogen Bonds
2011 Standout
BBR 3464: a novel triplatinum complex, exhibiting a preclinical profile of antitumor efficacy different from cisplatin.
2000
cis -Diammine(pyridine)chloroplatinum(II), a monofunctional platinum(II) antitumor agent: Uptake, structure, function, and prospects
2008 StandoutNobel
Angiotensin II Stimulation of NAD(P)H Oxidase Activity
2002
Fluorescein as an artificial enzyme to mimic peroxidase
2016
Alkyne Elementometalation−Pd-Catalyzed Cross-Coupling. Toward Synthesis of All Conceivable Types of Acyclic Alkenes in High Yields, Efficiently, Selectively, Economically, and Safely: “Green” Way
2010 StandoutNobel
Antitumour metal compounds: more than theme and variations
2007
Classical and Non‐Classical Ruthenium‐Based Anticancer Drugs: Towards Targeted Chemotherapy
2006
Ferrocene-Promoted Photoactivated DNA Cleavage and Anticancer Activity of Terpyridyl Copper(II) Phenanthroline Complexes
2010
Large-Scale Applications of Transition Metal-Catalyzed Couplings for the Synthesis of Pharmaceuticals
2011 Standout
Ferrocene-Conjugated l -Tryptophan Copper(II) Complexes of Phenanthroline Bases Showing DNA Photocleavage Activity and Cytotoxicity
2011
Thirty Years of the Drug Candidate NAMI‐A and the Myths in the Field of Ruthenium Anticancer Compounds: A Personal Perspective
2016
Advances in Copper Complexes as Anticancer Agents
2013 Standout
Dendrimers Designed for Functions: From Physical, Photophysical, and Supramolecular Properties to Applications in Sensing, Catalysis, Molecular Electronics, Photonics, and Nanomedicine
2010 Standout
Interaction of mismatch repair protein PMS2 and the p53-related transcription factor p73 in apoptosis response to cisplatin
2003
Circadian control of XPA and excision repair of cisplatin-DNA damage by cryptochrome and HERC2 ubiquitin ligase
2010 StandoutNobel
Optimization of cisplatin for the treatment of hormone dependent tumoral diseases
2009
Synthesis, Biochemical Properties and Molecular Modelling Studies of Organometallic Specific Estrogen Receptor Modulators (SERMs), the Ferrocifens and Hydroxyferrocifens: Evidence for an Antiproliferative Effect of Hydroxyferrocifens on both Hormone‐Dependent and Hormone‐Independent Breast Cancer Cell Lines
2003
Peptide Targeting of Platinum Anti-Cancer Drugs
2009
Works of Donato Colangelo being referenced
A Novel Trinuclear Platinum Complex Overcomes Cisplatin Resistance in an Osteosarcoma Cell System
1999
Water-soluble benzoheterocycle triosmium clusters as potential inhibitors of telomerase enzyme
2004
Electrochemical measurements confirm the preferential bonding of the antimetastatic complex [ImH][RuCl4(DMSO)(Im)] (NAMI-A) with proteins and the weak interaction with nucleobases
2004
Cis-[Pt(Cl)2(pyridine)(5-SO3H-isoquinoline)] complex, a selective inhibitor of telomerase enzymea
2003
Decreased Drug Accumulation and Increased Tolerance to DNA Damage in Tumor Cells with a Low Level of Cisplatin Resistance
1998
Cellular pharmacology of cisplatin in relation to the expression of human copper transporter CTR1 in different pairs of cisplatin-sensitive and -resistant cells
2004
Global gene expression of fission yeast in response to cisplatin
2004
Activity of a trinuclear platinum complex in human ovarian cancer cell lines sensitive and resistant to cisplatin: cytotoxicity and induction and gene-specific repair of DNA lesions
2001
γ-Glutamyl transpeptidase catalyses the extracellular detoxification of cisplatin in a human cell line derived from the proximal convoluted tubule of the kidney
2003
Might telomerase enzyme be a possible target for trans -Pt(II) complexes?
2003
Macrophage Stimulating Protein (MSP) evokes superoxide anion production by human macrophages of different origin
2001
Synthesis and characterisation of estrogenic carriers for cytotoxic Pt(ii) fragments: biological activity of the resulting complexes
2005
The cellular basis of the efficacy of the trinuclear platinum complex BBR 3464 against cisplatin-resistant cells
1999
Effects of Heparin and Its Desulfated Derivatives on Leukocyte-Endothelial Adhesion
1994
Tachykinin receptors on human monocytes: their involvement in rheumatoid arthritis
1998
The influence of temperature on antiproliferative effects, cellular uptake and DNA platination of the clinically employed Pt(II)-drugs
2007
Development of resistance to a trinuclear platinum complex in ovarian carcinoma cells
2003
Pt(II) complexes with different N-donor aromatic ligands for specific inhibition of telomerase
2000
Monoclonal Antibody-Targeted Fluorescein-5-isothiocyanate-Labeled Biomimetic Nanoapatites: A Promising Fluorescent Probe for Imaging Applications
2015
FACS analysis of oxidative stress induced on tumour cells by SERMs
2004
Bioinorganic Chemistry: The Study of the Fate of Platinum-Based Antitumour Drugs
2007
Water Stability and Cytotoxic Activity Relationship of a Series of Ferrocenium Derivatives. ESR Insights on the Radical Production during the Degradation Process
2002